Leveraging ToF-SIMS imaging to investigate tenofovir disoproxil fumarate degradation at excipient interfaces in oral compressed tablets

J Pharm Biomed Anal. 2024 Feb 15:239:115863. doi: 10.1016/j.jpba.2023.115863. Epub 2023 Nov 19.

Abstract

Time-of-flight secondary ion mass spectrometry (ToF-SIMS) imaging has been used to study the hydrolysis of tenofovir disoproxil fumarate (TDF) to tenofovir monosoproxil (TM) within an oral compressed tablet. The ToF-SIMS images displayed a heterogenous distribution of the matrix components. Evaluation of the TM distribution revealed that it was primarily co-localized with areas of higher excipient concentration pointing toward excipient driven degradation. To support these observations, a compatibility study of TDF with each tablet component was performed via liquid chromatography. The ToF-SIMS imaging and compatibility study indicated that the excipient, Avicel® PH-102, was the primary driver of TM formation in the tablet. The hydrolysis degradation mechanism within the tablet is further rationalized through discussion of chemical and physical properties of the matrix components. The sum of this work demonstrates a new analytical workflow for probing and understanding matrix driven degradation in oral compressed tablets utilizing ToF-SIMS imaging.

Keywords: API-excipient interactions; Degradation; Mass spectrometry imaging; Oral compressed tablets; Tenofovir disoproxil fumarate.

MeSH terms

  • Anti-HIV Agents* / therapeutic use
  • Excipients / chemistry
  • HIV Infections* / drug therapy
  • Humans
  • Spectrometry, Mass, Secondary Ion
  • Tablets / chemistry
  • Tenofovir / therapeutic use

Substances

  • Tenofovir
  • Anti-HIV Agents
  • Excipients
  • Tablets